Brainsway Deep TMS vs. Antidepressants for Major Depressive Disorder Efficacy
In the NIH-sponsored STAR*D study (Sequenced Treatment Alternatives to Relieve Depression) it was found that 63.2% of patients suffering from major depression fail to benefit from the first line of antidepressant treatment. 33% of patients do not respond to any drug treatment.1
Brainsway Deep TMS was tested in patients who failed to benefit from at least one antidepressant, and was found effective even for patients who failed to benefit from several prior antidepressant medications2
It is noteworthy that in real-life clinical practice settings, many patients receive Deep TMS therapy concomitantly with antidepressants. Continued antidepressant use is not contraindicated in patients receiving Deep TMS.